Published in Am J Pathol on March 01, 1997
Paraneoplastic leukemoid reaction in a patient with BRAF V600E-mutated metastatic malignant melanoma. BMJ Case Rep (2015) 0.75
G-CSF increases secretion of urokinase-type plasminogen activator by human lung cancer cells. Clin Exp Metastasis (1998) 0.75
The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell (1982) 19.91
In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst (1973) 11.26
Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell (1991) 9.73
Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature (1986) 7.73
Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci U S A (1976) 6.82
The human hematopoietic colony-stimulating factors. Science (1987) 5.86
Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst (1988) 5.42
Improved techniques for the induction of mammalian cell hybridization by polyethylene glycol. Somatic Cell Genet (1976) 5.05
The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature (1989) 4.43
Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell (1991) 3.21
Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci U S A (1985) 3.02
Inhibition of tumor growth by elimination of granulocytes. J Exp Med (1995) 2.65
Growth factors in development, transformation, and tumorigenesis. Cell (1991) 2.49
IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol (1993) 2.44
Monoclonal antibodies to human intermediate filament proteins. II. Distribution of filament proteins in normal human tissues. Am J Pathol (1984) 2.42
Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line. Int J Cancer (1991) 2.26
Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res (1984) 2.13
Isolation and characterization of the cDNA encoding human DNA methyltransferase. Nucleic Acids Res (1992) 2.10
Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells. Blood (1989) 2.02
Isolation and characterization of the cDNA for murine granulocyte colony-stimulating factor. Proc Natl Acad Sci U S A (1986) 1.94
Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res (1992) 1.54
DNA methylation and cancer. Cancer Res (1986) 1.47
Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage. Cancer Res (1993) 1.32
Immunohistochemical study on the distribution of alpha and beta subunits of S-100 protein in human neoplasm and normal tissues. Virchows Arch B Cell Pathol Incl Mol Pathol (1984) 1.28
Purification and characterization of human granulocyte colony-stimulating factor (G-CSF). EMBO J (1986) 1.24
Overexpression of the granulocyte colony-stimulating factor gene leads to osteoporosis in mice. Lab Invest (1996) 1.18
Biochemical characterization and cellular localization of a formalin-resistant melanoma-associated antigen reacting with monoclonal antibody NKI/C-3. Int J Cancer (1985) 1.18
A rapid procedure for isolation of RNA-free genomic DNA from mammalian cells. Biotechniques (1993) 1.14
Suppression of spontaneous melanoma metastasis in scid mice with an antibody to the epidermal growth factor receptor. Cancer Res (1991) 1.13
Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood (1992) 1.11
Characterizations of the extracellular matrix and proteinase inhibitor content of human myoepithelial tumors. Lab Invest (1996) 1.05
The frequency and clinical biology of the ectopic hormone syndromes of small cell carcinoma. Cancer (1982) 1.01
Gangliosides of human melanoma: GM2 and tumorigenicity. J Natl Cancer Inst (1987) 1.00
Myeloid haemopoietic growth factors. Biochim Biophys Acta (1989) 0.95
Further evidence for a novel receptor for amino-terminal parathyroid hormone-related protein on keratinocytes and squamous carcinoma cell lines. Endocrinology (1995) 0.94
Exceptional lethality for nude mice of cells derived from a primary human melanoma. Cancer Res (1985) 0.93
Role of growth factors and their receptors in the development and progression of melanoma. J Invest Dermatol (1993) 0.93
Multiple elements in the promoter of granulocyte colony-stimulating factor gene regulate its constitutive expression in human carcinoma cells. J Biol Chem (1990) 0.92
Three essential promoter elements mediate tumour necrosis factor and interleukin-1 activation of the granulocyte-colony stimulating factor gene. Growth Factors (1992) 0.92
Human breast cancer progression can be regulated by dominant trans-acting factors in somatic cell hybridization studies. Cancer Res (1996) 0.90
Predominance of the metastatic phenotype in somatic cell hybrids of the K-1735 murine melanoma. Cancer Res (1991) 0.89
The primary tumor is the primary source of metastasis in a human melanoma/SCID model. Implications for the direct autocrine and paracrine epigenetic regulation of the metastasis process. Int J Cancer (1996) 0.84
The use of cell fusion to analyse factors involved in tumour cell metastasis. Int J Cancer (1983) 0.83
Production of granulocyte colony-stimulating factor by a human melanoma cell line. Exp Hematol (1987) 0.83
Studies on the role of recombinant human erythropoietin in the growth regulation of human nonhematopoietic tumor cells in vitro. Ann Hematol (1991) 0.83
Molecular cloning and characterization of a cDNA for human granulocyte colony-stimulating factor (G-CSF) from a glioblastoma multiforme cell line and localization of the G-CSF gene to chromosome band 17q21. Oncogene Res (1987) 0.81
Ectopic secretion of neurohypophyseal peptides in patients with malignancy. Endocrinol Metab Clin North Am (1991) 0.81
Erythropoietin production. A potential marker for interleukin-2/interferon-responsive tumors. Cancer (1993) 0.81
Immunolocalization of granulocyte-colony-stimulating factor in human glial and primitive neuroectodermal tumors. Int J Cancer (1994) 0.81
Molecular cloning of cDNAs for the human granulocyte colony-stimulating factor receptor from HL-60 and mapping of the gene to chromosome region 1p32-34. Blood (1992) 0.80
Expression of c-jun, jun-B, and c-fos proto-oncogenes in human primary melanocytes and metastatic melanomas. J Invest Dermatol (1991) 0.80
Suppression of tumorigenicity of a human lung carcinoma line by nontumorigenic bronchial epithelial cells in somatic cell hybrids. Cancer Res (1990) 0.80
DNA ploidy analysis of cervical condyloma and intraepithelial neoplasia in specimens obtained by punch biopsy. Anal Quant Cytol Histol (1989) 0.80
Parathyroid hormone-related protein expression in gynecic squamous carcinoma cells. Cancer (1994) 0.78
Tumor invasion and the extracellular matrix. Lab Invest (1983) 3.81
Isolation of a tumor cell laminin receptor. Biochem Biophys Res Commun (1983) 3.05
Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest (1997) 2.28
Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis. Am J Surg Pathol (1996) 2.20
The human myoepithelial cell is a natural tumor suppressor. Clin Cancer Res (1997) 2.08
The nature and evolution of port wine stains: a computer-assisted study. J Invest Dermatol (1980) 2.00
Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest (1983) 1.91
Breast-cancer diagnosis with nipple fluid bFGF. Lancet (2000) 1.86
Airway inflammation in young marijuana and tobacco smokers. Am J Respir Crit Care Med (1998) 1.86
An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Cancer Res (2001) 1.65
A novel human xenograft model of inflammatory breast cancer. Cancer Res (1999) 1.61
Human breast carcinoma desmoplasia is PDGF initiated. Oncogene (2000) 1.59
Increased content of Type V Collagen in desmoplasia of human breast carcinoma. Am J Pathol (1982) 1.59
Treatment of the chronic iliolumbar syndrome by infiltration of the iliolumbar ligament. West J Med (1982) 1.57
Altered mucin expression is a field change that accompanies mucinous (colloid) breast carcinoma histogenesis. Hum Pathol (1998) 1.54
The myoepithelial defense: a host defense against cancer. Med Hypotheses (1997) 1.53
Lactational competence and involution of the mouse mammary gland require plasminogen. Development (2000) 1.48
Laminin molecular domains which alter metastasis in a murine model. J Clin Invest (1984) 1.43
Intravascular papillary endothelial hyperplasia: a neoplastic "actor" representing an exaggerated attempt at recanalization mediated by basic fibroblast growth factor. J Hand Surg Am (1994) 1.41
Port wine stains and the response to argon laser therapy: successful treatment and the predictive role of color, age, and biopsy. Plast Reconstr Surg (1980) 1.39
Diagnostic immunopathology. West J Med (1986) 1.38
The significance of matrix metalloproteinases during early stages of tumor progression. Ann N Y Acad Sci (1998) 1.37
ERalpha signaling through slug regulates E-cadherin and EMT. Oncogene (2010) 1.35
Monoclonal antibodies to the human laminin receptor recognize structurally distinct sites. Exp Cell Res (1985) 1.32
Thymus involution in the acquired immunodeficiency syndrome. Am J Clin Pathol (1985) 1.28
Tamoxifen enhances myoepithelial cell suppression of human breast carcinoma progression in vitro by two different effector mechanisms. Cancer Lett (2000) 1.23
Cardiac rupture during myocardial infarction. A review of 44 cases. Circulation (1972) 1.21
Use of anti-basement membrane antibodies to distinguish blood vessel capillaries from lymphatic capillaries. Am J Surg Pathol (1983) 1.17
The human myoepithelial cell exerts antiproliferative effects on breast carcinoma cells characterized by p21WAF1/CIP1 induction, G2/M arrest, and apoptosis. Exp Cell Res (1998) 1.15
Fiberoptic ductoscopy for patients with nipple discharge. Cancer (2000) 1.14
Stages of neoplastic transformation of human breast tissue as monitored by dissolution of basement membrane components. An immunoperoxidase study. Invasion Metastasis (1981) 1.14
HL-A antigens in myasthenia gravis. Lancet (1974) 1.14
Iliolumbar syndrome as a common cause of low back pain: diagnosis and prognosis. Arch Phys Med Rehabil (1979) 1.14
Hepatocellular carcinoma with carcinoid features. Hum Pathol (1984) 1.11
Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res (1998) 1.11
Increased invasion and spontaneous metastasis of BL6 melanoma with inhibition of the desmoplastic response in C57 BL/6 mice. Cancer Res (1987) 1.09
Evidence for a protein related immunologically to the jaagsiekte sheep retrovirus in some human lung tumours. Eur Respir J (2000) 1.08
The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype. Oncogene (2000) 1.07
Semi-automated imaging system to quantitate estrogen and progesterone receptor immunoreactivity in human breast cancer. J Microsc (2007) 1.06
Characterizations of the extracellular matrix and proteinase inhibitor content of human myoepithelial tumors. Lab Invest (1996) 1.05
Association of HLA-B8, DRw3, and anti-acetylcholine receptor antibodies in myasthenia gravis. Tissue Antigens (1978) 1.03
Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by P21WAF1/CIP1 induction, G2/M arrest, and apoptosis. J Cell Biochem (1998) 1.01
Arginase deficiency manifesting delayed clinical sequelae and induction of a kidney arginase isozyme. Hum Genet (1993) 1.00
Vascular expression of E-selectin is increased in estrogen-receptor-negative breast cancer: a role for tumor-cell-secreted interleukin-1 alpha. Am J Pathol (1997) 1.00
Breast-duct endoscopy to study stages of cancerous breast disease. Lancet (1996) 1.00
Tumor promoter-induced membrane-bound protein kinase C regulates hematogenous metastasis. Proc Natl Acad Sci U S A (1988) 0.98
Characterization of a laminin receptor from human breast carcinoma tissue. Breast Cancer Res Treat (1984) 0.98
Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran. Cancer (1998) 0.98
Different patterns of angiogenesis in sarcomas and carcinomas. Clin Cancer Res (1999) 0.97
Peliosis hepatis. Possible etiologic role of anabolic steroids. Arch Pathol (1973) 0.97
Sarcoma arising in a residual testicular teratoma after cytoreductive chemotherapy. Cancer (1984) 0.96
Malignant mixed tumor (carcinosarcoma) of the pancreas: a case report supporting organ-induced differentiation of malignancy. Surgery (1994) 0.95
Type IV collagenase immunoreactivity in invasive breast carcinoma. Lancet (1983) 0.94
Desmoplastic breast carcinoma as a source of human myofibroblasts. Am J Pathol (1984) 0.94
"Low grade" mucoepidermoid carcinoma of the bronchus with "high grade" biological behavior. Cancer (1983) 0.94
An update on core needle biopsy for radiologically detected breast lesions. Cancer (1996) 0.94
Detection of cytomegalovirus DNA in classic and epidemic Kaposi's sarcoma by in situ hybridization. Hum Pathol (1988) 0.93
In vitro cellular aging in T-lymphocyte cultures: analysis of DNA content and cell size. Exp Cell Res (1993) 0.92
Human colon cancer cells express multiple glycoprotein ligands for E-selectin. Int J Oncol (2000) 0.92
Nodular lymphoma with intracellular immunoglobulin. Cancer (1979) 0.92
The extracellular matrix of pulmonary scar carcinomas is suggestive of a desmoplastic origin. Am J Pathol (1986) 0.90
Synchronous occurrence of malignant rhabdoid tumor two decades after Wilms' tumor irradiation. Am J Surg Pathol (1993) 0.90
Prognostic role of p27Kip1 and apoptosis in human breast cancer. Br J Cancer (1999) 0.90
Human breast cancer progression can be regulated by dominant trans-acting factors in somatic cell hybridization studies. Cancer Res (1996) 0.90
The in vitro senescence of human T lymphocytes: failure to divide is not associated with a loss of cytolytic activity or memory T cell phenotype. Mech Ageing Dev (1993) 0.90
The genesis and unique properties of the lymphovascular tumor embolus are because of calpain-regulated proteolysis of E-cadherin. Oncogene (2012) 0.90
Immunocytochemical enhancement of basement membrane antigens by pepsin: applications in diagnostic pathology. Am J Clin Pathol (1984) 0.89
Pachydermodactyly. Clin Orthop Relat Res (1985) 0.89
The lymphovascular embolus of inflammatory breast cancer exhibits a Notch 3 addiction. Oncogene (2010) 0.88
Mixed tumors of the salivary glands. Growth pattern and recurrence. Arch Pathol Lab Med (1976) 0.86
Fiberoptic ductoscopy for breast cancer patients with nipple discharge. Surg Endosc (2001) 0.86
Strong HLA-DR expression in T cell cultures after activation is necessary for IL-2-dependent proliferation. Hum Immunol (1983) 0.86
Hydrophobic association of calpains with subcellular organelles. Compartmentalization of calpains and the endogenous inhibitor calpastatin in tissues. J Biol Chem (1986) 0.86
Disturbance of redistribution of surface membrane receptors on peripheral mononuclear cells of patients with Down's syndrome and of aged individuals. J Gerontol (1980) 0.86
Myoepithelial-specific CD44 shedding contributes to the anti-invasive and antiangiogenic phenotype of myoepithelial cells. Exp Cell Res (2000) 0.86
Letter: HL-A antigens in myasthenia gravis. Lancet (1974) 0.86
Benign phyllodes tumor of the breast: MR imaging features. AJR Am J Roentgenol (1996) 0.85
Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines. J Natl Cancer Inst (1993) 0.84
Diagnostic accuracy and use of aspiration biopsy in the management of thyroid nodules. Arch Intern Med (1984) 0.84
The primary tumor is the primary source of metastasis in a human melanoma/SCID model. Implications for the direct autocrine and paracrine epigenetic regulation of the metastasis process. Int J Cancer (1996) 0.84
The laminin receptor and basement membrane dissolution: role in tumour metastasis. Ciba Found Symp (1984) 0.83
Tumour desmoplasia inhibits angiogenesis. Lancet (1987) 0.83
Ataxia-telangiectasia: flow cytometric cell-cycle analysis of lymphoblastoid cell lines in G2/M before and after gamma-irradiation. Mod Pathol (1994) 0.83
Severe platelet dysfunction in hairy cell leukemia with improvement after splenectomy. Blood (1980) 0.83
Dialysis-induced changes in muscle strength. J Dial (1980) 0.82
Chronic lymphocytic leukemia presenting as a pituitary mass lesion. Can J Neurol Sci (1992) 0.82
Morphologic aspects of bone marrow transplantation in patients with aplastic anemia. Hum Pathol (1978) 0.82
'Revertant' DCIS in human axillary breast carcinoma metastases. J Pathol (1997) 0.82
Myoepithelial-specific CD44 shedding is mediated by a putative chymotrypsin-like sheddase. Biochem Biophys Res Commun (2000) 0.81
Genistein inhibits both constitutive and EGF-stimulated invasion in ER-negative human breast carcinoma cell lines. Anticancer Res (1998) 0.81
Endothelium-specific expression of an E-selectin promoter recombinant adenoviral vector. Anticancer Res (1998) 0.81
Genistein's "ER-dependent and independent" actions are mediated through ER pathways in ER-positive breast carcinoma cell lines. Anticancer Res (2000) 0.81
Humatrix, a novel myoepithelial matrical gel with unique biochemical and biological properties. Cancer Lett (1998) 0.81
Desmoplastic basal cell carcinomas possess unique basement membrane-degrading properties. J Invest Dermatol (1987) 0.81
Acute lymphoblastic leukemia with giant intracytoplasmic inclusions. Am J Clin Pathol (1980) 0.81